Air Products and Chemicals Inc (APD)
Official siteBASIC MATERIALS • SPECIALTY CHEMICALS • NYSE
Market Cap: $70.49B
Last updated: Nov 17, 2026 at 11:04 AM ET
Air Products and Chemicals Inc (APD) Financials: Revenue, Profit and Cash Flow
Air Products and Chemicals reported revenue of $12.04B for the fiscal year ended Sep 30, 2025, down 0.5% from the year before. That year, net income was -$354.40M with a net margin of -2.9%, operating cash flow was $3.26B and free cash flow was -$3.77B. The quarter ended Jun 30, 2026 had revenue of $3.16B and net income of -$1.42B.
Revenue and Margins
The operating margin was -7.3% in the fiscal year ended Sep 2025, the lowest of the 10 years shown. Over the 9 years to Sep 2025, revenue grew from $7.50B, a compound annual rate of 5.4%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Sep 2025 | $12.04B | -0.5% | 31.4% | -7.3% | -2.9% |
| Sep 2024 | $12.10B | -4.0% | 32.5% | 36.9% | 31.9% |
| Sep 2023 | $12.60B | -0.8% | 29.9% | 19.8% | 18.6% |
| Sep 2022 | $12.70B | +23.0% | 26.5% | 18.4% | 17.8% |
| Sep 2021 | $10.32B | +16.6% | 30.4% | 22.1% | 20.5% |
| Sep 2020 | $8.86B | -0.7% | 33.9% | 25.3% | 21.8% |
| Sep 2019 | $8.92B | -0.1% | 33.0% | 24.0% | 20.3% |
| Sep 2018 | $8.93B | +9.1% | 30.7% | 22.0% | 17.2% |
| Sep 2017 | $8.19B | +9.1% | 29.8% | 17.6% | 36.9% |
| Sep 2016 | $7.50B | N/A | 31.0% | 20.5% | 8.8% |
Income Statement
In the fiscal year ended Sep 2025, the company posted a net loss after a profit the year before. In the quarter ended Jun 2026, the company posted a net loss after a profit in the same quarter a year earlier.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.04B | $12.10B | $12.60B | $12.70B | $10.32B | $8.86B | $8.92B | $8.93B | $8.19B | $7.50B |
| Cost of revenue | $8.26B | $8.17B | $8.83B | $9.34B | $7.19B | $5.86B | $5.98B | $6.19B | $5.75B | $5.18B |
| Gross profit | $3.78B | $3.93B | $3.77B | $3.36B | $3.14B | $3.00B | $2.94B | $2.74B | $2.44B | $2.33B |
| Research and development | $96.30M | $100.20M | $105.60M | $102.90M | $93.50M | $83.90M | $72.90M | $64.50M | $57.60M | $71.80M |
| Operating income | -$877.00M | $4.47B | $2.49B | $2.34B | $2.28B | $2.24B | $2.14B | $1.97B | $1.44B | $1.54B |
| Net income | -$354.40M | $3.86B | $2.34B | $2.27B | $2.11B | $1.93B | $1.81B | $1.53B | $3.02B | $661.50M |
| EBITDA | $689.80M | $5.84B | $3.81B | $3.74B | $3.68B | $3.45B | $3.29B | $2.94B | $2.32B | $2.38B |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.16B | $3.17B | $3.10B | $3.17B | $3.02B | $2.92B | $2.93B | $3.19B | $2.99B | $2.93B | $3.00B | $3.19B |
| Gross profit | $1.04B | $987.40M | $995.00M | $1.02B | $982.60M | $862.30M | $915.00M | $1.08B | $979.90M | $938.70M | $930.20M | $984.10M |
| Operating income | -$2.10B | $752.70M | $734.50M | $16.80M | $790.60M | -$2.33B | $643.60M | $2.42B | $737.60M | $637.20M | $666.90M | $738.60M |
| Net income | -$1.42B | $724.80M | $691.40M | $10.10M | $723.20M | -$1.74B | $649.80M | $1.95B | $708.90M | $580.90M | $621.60M | $694.40M |
Balance Sheet
As of Sep 2025, total debt of $17.70B exceeded cash and equivalents by $15.84B.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $41.06B | $39.57B | $32.00B | $27.19B | $26.86B | $25.17B | $18.94B | $19.18B | $18.47B | $18.03B |
| Current assets | $5.83B | $6.36B | $5.20B | $6.28B | $8.38B | $8.68B | $4.62B | $5.08B | $5.88B | $4.32B |
| Cash and equivalents | $1.86B | $2.98B | $1.62B | $2.71B | $4.47B | $5.25B | $2.25B | $2.79B | $3.27B | $1.29B |
| Total liabilities | $23.71B | $20.90B | $16.34B | $13.49B | $12.77B | $12.73B | $7.55B | $8.00B | $8.28B | $10.82B |
| Short-term debt | $751.00M | $694.90M | $874.50M | $688.00M | $486.90M | $477.70M | $98.60M | $460.90M | $560.40M | $1.30B |
| Long-term debt | $16.95B | $13.53B | $9.43B | $7.09B | $7.15B | $7.43B | $3.23B | $3.35B | $3.40B | $3.91B |
| Shareholder equity | $15.02B | $17.04B | $14.31B | $13.14B | $13.54B | $12.08B | $11.05B | $10.86B | $10.09B | $7.08B |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $40.45B | $41.64B | $41.24B | $41.06B | $41.66B | $38.87B | $40.02B | $39.57B | $36.97B | $35.92B | $34.12B | $32.00B |
| Total liabilities | $23.85B | $23.49B | $23.40B | $23.71B | $23.89B | $22.09B | $21.28B | $20.90B | $20.29B | $19.59B | $17.99B | $16.34B |
| Cash and equivalents | $980.50M | $951.00M | $1.03B | $1.86B | $2.32B | $1.49B | $1.85B | $2.98B | $2.38B | $2.54B | $1.96B | $1.62B |
| Shareholder equity | $13.88B | $15.65B | $15.41B | $15.02B | $15.54B | $14.70B | $16.69B | $17.04B | $15.10B | $14.91B | $14.87B | $14.31B |
Cash Flow
In the fiscal year ended Sep 2025, capital expenditures exceeded operating cash flow, leaving negative free cash flow.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.26B | $3.65B | $3.21B | $3.17B | $3.34B | $3.26B | $2.97B | $1.09B | $2.53B | $2.22B |
| Capital expenditures | $7.02B | $6.80B | $4.63B | $2.93B | $2.46B | $2.51B | $1.99B | $1.57B | $1.04B | $907.70M |
| Free cash flow | -$3.77B | -$3.15B | -$1.42B | $244.10M | $871.00M | $755.70M | $980.20M | -$476.80M | $1.49B | $1.32B |
| Dividends paid | $1.59B | $1.59B | $1.61B | $1.38B | $1.26B | $1.10B | $994.00M | $897.80M | $787.90M | $721.20M |
| Investing cash flow | -$7.17B | -$4.92B | -$5.92B | -$3.86B | -$2.73B | -$3.56B | -$2.11B | -$1.64B | -$1.41B | -$909.40M |
| Financing cash flow | $2.80B | $2.62B | $1.61B | -$1.00B | -$1.42B | $3.28B | -$1.37B | -$1.36B | -$2.04B | -$860.20M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.31B | $1.10B | $900.70M | $1.26B | $855.80M | $328.10M | $811.70M | $957.00M | $1.26B | $801.70M | $626.60M | $1.00B |
| Capital expenditures | $995.70M | $1.11B | $1.25B | $1.52B | $1.50B | $1.89B | $2.12B | $2.08B | $1.61B | $1.67B | $1.45B | $1.46B |
| Free cash flow | $309.50M | -$3.90M | -$350.50M | -$256.50M | -$640.00M | -$1.56B | -$1.31B | -$1.12B | -$345.20M | -$867.70M | -$818.90M | -$460.60M |
Frequently Asked Questions About APD
What is Air Products and Chemicals' annual revenue?
Air Products and Chemicals reported revenue of $12.04B for the fiscal year ended Sep 30, 2025.
How fast is Air Products and Chemicals' revenue growing?
Revenue was down 0.5% for the fiscal year ended Sep 30, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -1.8%.
Is Air Products and Chemicals profitable?
No. Air Products and Chemicals reported net income of -$354.40M for the fiscal year ended Sep 30, 2025, with a net margin of -2.9%.
How much free cash flow does APD generate?
For the fiscal year ended Sep 30, 2025, operating cash flow of $3.26B minus capital expenditures of $7.02B produced free cash flow of -$3.77B.
How much debt does Air Products and Chemicals have?
The balance sheet dated Sep 30, 2025 reported long-term debt of $16.95B, short-term debt of $751.00M and cash and equivalents of $1.86B.
APD pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts